These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4572051)

  • 41. Comparison of efficacy of amoxapine and imipramine in a multi-clinic double-blind study using the WHO schedule for a standard assessment of patients with depressive disorders.
    Takahashi R; Sakuma A; Hara T; Kazamatsuri H; Mori A; Saito Y; Murasaki M; Oguchi T; Sakurai Y; Yuzuriha T; Takemura M; Kurokawa H; Kurita H
    J Int Med Res; 1979; 7(1):7-18. PubMed ID: 369926
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A placebo-controlled inpatient comparison of fluvoxamine maleate and imipramine in major depression.
    Feighner JP; Boyer WF; Meredith CH; Hendrickson GG
    Int Clin Psychopharmacol; 1989 Jul; 4(3):239-44. PubMed ID: 2507630
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A double-blind controlled clinical trial comparing fluvoxamine with imipramine.
    Guelfi JD; Dreyfus JF; Pichot P
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):411S-417S. PubMed ID: 6407501
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Minaprine and imipramine in the treatment of major depressive disorders. A comparative double-blind study.
    Bohacek N; Ravic M; Bizière K
    Drugs Exp Clin Res; 1987; 13(7):435-42. PubMed ID: 3308390
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A double-blind placebo-controlled study of fluvoxamine and imipramine in depression.
    Dominguez RA; Goldstein BJ; Jacobson AF; Steinbook RM
    J Clin Psychiatry; 1985 Mar; 46(3):84-7. PubMed ID: 3918993
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Speed of onset of action of the newer antidepressants.
    Lydiard RB; Pottash AL; Gold MS
    Psychopharmacol Bull; 1984; 20(2):258-71. PubMed ID: 6374722
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of iprindole on amine uptake in man.
    Fann WE; Davis JM; Janowsky DS; Kaufmann JS; Griffith JD; Oates JA
    Arch Gen Psychiatry; 1972 Feb; 26(2):158-62. PubMed ID: 5060401
    [No Abstract]   [Full Text] [Related]  

  • 48. Comparative trial of imipramine N-oxide and imipramine in the treatment of out-patients with depressive syndromes.
    Rapp W; Norén MB; Pedersen F
    Acta Psychiatr Scand; 1973; 49(1):77-90. PubMed ID: 4572170
    [No Abstract]   [Full Text] [Related]  

  • 49. A double-blind comparison of fluvoxamine, imipramine and placebo in depressed patients.
    Norton KR; Sireling LI; Bhat AV; Rao B; Paykel ES
    J Affect Disord; 1984 Dec; 7(3-4):297-308. PubMed ID: 6241211
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Depressions treated with imipramine-N-oxide and imipramine. A controlled double-blind trial].
    Ose E
    Tidsskr Nor Laegeforen; 1971 Nov; 91(33):2388-94. PubMed ID: 4943561
    [No Abstract]   [Full Text] [Related]  

  • 51. Brofaromine in elderly major depressed patients--a comparative trial versus imipramine.
    Möller HJ; Volz HP
    Eur Neuropsychopharmacol; 1993 Dec; 3(4):501-10. PubMed ID: 8111223
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [A double-blind comparison between mianserin and imipramine (author's transl)].
    Pull CB; Pichot P; Dreyfus JF
    Acta Psychiatr Belg; 1978; 78(5):827-32. PubMed ID: 375686
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder.
    Amsterdam JD; Kaplan M; Potter L; Bloom L; Rickels K
    Psychopharmacology (Berl); 1986; 88(4):484-8. PubMed ID: 3085137
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multicentric double-blind study comparing efficacy and safety of minaprine and imipramine in dysthymic disorders.
    Salzmann E; Robin JL
    Neuropsychobiology; 1995; 31(2):68-75. PubMed ID: 7760988
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A double-blind evaluation of nomifensine and imipramine in depressed outpatients.
    McCawley A
    Am J Psychiatry; 1979 Jun; 136(6):841-3. PubMed ID: 375757
    [No Abstract]   [Full Text] [Related]  

  • 56. Comparison of Vivalan (viloxazine hydrochloride) with imipramine in the treatment of depression. A double-blind study.
    Santonastaso P; Maistrello I; Battistin L
    Acta Psychiatr Scand; 1979 Aug; 60(2):137-43. PubMed ID: 388987
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Trazodone efficacy and safety in endogenous depression: a double blind comparison with imipramine.
    Al-Yassiri MM; Bridges PK
    Neuropharmacology; 1980 Dec; 19(12):1191-3. PubMed ID: 7003426
    [No Abstract]   [Full Text] [Related]  

  • 58. Controlled randomized group comparison of nomifensine and imipramine in depressive illness.
    Forrest A; Hewett A; Nicholson P
    Br J Clin Pharmacol; 1977; 4Suppl 2(Suppl 2):215S-220S. PubMed ID: 334226
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A double-blind multicentre trial comparing mianserin with imipramine.
    Pichot P; Dreyfus JF; Pull C
    Br J Clin Pharmacol; 1978; 5 Suppl 1(Suppl 1):87S-90S. PubMed ID: 341950
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Iprindole, a new antidepressant for use in general office practice. A double blind, placebo-controlled study.
    Hicks JT
    IMJ Ill Med J; 1965 Dec; 128(6):622-6. PubMed ID: 4379035
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.